Abstract:Acrylamide (ACR) exposure and consequent health hazards are alarming public health issues that attract worldwide concern. The World Health Organization urges more researches into health hazards from ACR exposure. However, whether and how ACR exposure increases cardiovascular risk remain unclear, and we sought to address these issues in this prospective cohort study conducted on 3024 general adults with 3-year follow-up (N=871 at follow-up). Individual urinary ACR metabolites (N-Acetyl-S-(2-carbamoylethyl)-L-cysteine [AAMA] and N-Acetyl-S-(2-carbamoyl-2-hydroxyethyl)-L-cysteine [GAMA]) as credible biomarkers of ACR exposure were detected to assess their cross-sectional and longitudinal relationships with 10-year cardiovascular disease (CVD) risk, a well measure of overall cardiovascular risk. Besides, biomarkers of oxidative stress (urinary 8-hydroxy-deoxyguanosine [8-OHdG] and 8-iso-prostaglandin-F2α [8-iso-PGF2α]) and inflammation (circulating mean platelet volume [MPV] and plasma C-reactive protein [CRP]) as well as plasma transforming growth factor-β1 (TGF-β1) were measured to assess their mediating/mechanistic roles in the relationships of ACR metabolites with 10-year CVD risk. We found AAMA, GAMA, and ΣUAAM (AAMA+GAMA) were cross-sectionally and longitudinally related to increased 10-year CVD risk with odds ratios (95% confidence intervals [CIs]) of 1.32 (1.04, 1.70), 1.81 (1.36, 2.40), and 1.40 (1.07, 1.82), respectively, and risk ratios (95% CIs) of 1.99 (1.10, 3.60), 2.48 (1.27, 4.86), and 2.13 (1.15, 3.94), respectively. Furthermore, 8-OHdG, 8-iso-PGF2α, MPV, CRP, and TGF-β1 were found to significantly mediate 8.06-48.92% of the ACR metabolites-associated 10-year CVD risk increment. In summary, daily ACR exposure of general adults was cross-sectionally and longitudinally associated with increased cardiovascular risk, which was partly mediated by oxidative stress, inflammation, and TGF-β1, suggesting for the first time that ACR exposure may well increase cardiovascular risk of general adult population partly by mechanisms of inducing oxidative stress, inflammation, and TGF-β1. Our findings have important public health implications that provide potent epidemiological evidence and vital mechanistic insight into cardiovascular risk increment from ACR exposure.

Associations of Hemoglobin Biomarker Levels of Acrylamide and All-Cause and Cardiovascular Disease Mortality among U.S. Adults: National Health and Nutrition Examination Survey 2003–2006

Exposure to Acrylamide and the Risk of Cardiovascular Diseases in the National Health and Nutrition Examination Survey 2003–2006

Association of Acrylamide Hemoglobin Biomarkers with Obesity, Abdominal Obesity and Overweight in General US Population: NHANES 2003-2006

Relationships Between Acrylamide and Glycidamide Hemoglobin Adduct Levels and Allergy-Related Outcomes in General Us Population, Nhanes 2005-2006

Associations of Acrylamide with Non-Alcoholic Fatty Liver Disease in American Adults: a Nationwide Cross-Sectional Study

Associations of Hemoglobin Adducts of Acrylamide and Glycidamide with Prevalent Metabolic Syndrome in a Nationwide Population-Based Study.

The association between biomarkers of acrylamide and cancer mortality in U.S. adult population: Evidence from NHANES 2003-2014

Relationship between acrylamide and glycidamide hemoglobin adduct levels and osteoarthritis: a NHANES analysis

Differences in hemoglobin adduct levels of acrylamide in the general population with respect to dietary intake, smoking habits and gender

Biomarker Analysis of Hemoglobin Adducts of Acrylamide and Glycidamide Enantiomers for Mid-Term Internal Exposure Assessment by Isotope Dilution Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry.

Adduction of Biomacromolecules with Acrylamide (aa) in Mice at Environmental Dose Levels Studied by Accelerator Mass Spectrometry

Estimation of intake and quantification of hemoglobin adducts of acrylamide in adolescents in Sweden

Acrylamide exposure increases cardiovascular risk of general adult population probably by inducing oxidative stress, inflammation, and TGF-β1: A prospective cohort study

Association of Glycated Albumin to Hemoglobin A1c Ratio with All-Cause and Cardiovascular Mortality among US Adults: a Population-Based Cohort Study.

Adolescence is a sensitive period for acrylamide-induced sex hormone disruption: Evidence from NHANES populations and experimental mice

Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance Hemodialysis

Exposure to acrylamide and reduced heart rate variability: The mediating role of transforming growth factor-β

Abstract 027: Cumulative Consumption of Sulfur Amino Acids and Risks of Cardiovascular Disease and Mortality; Analysis of Two Prospective Cohort Studies

Exposure to acrylamide and increased risk of depression mediated by inflammation, oxidative stress, and alkaline phosphatase: Evidence from a nationally representative population-based study

Association of the hemoglobin glycation index with cardiovascular and all-cause mortality in individuals with hypertension: findings from NHANES 1999–2018

Associations of arsenic exposure with liver injury in US adults: NHANES 2003–2018